Prof. Eytan Ruppin National Institutes of Health (NIH), USA

Eytan Ruppin received his M.D. and Ph.D. from Tel-Aviv University where he has served as a Professor of Computer Science & Medicine since 1995, conducting computational multi-disciplinary research spanning computational neuroscience, natural language processing, machine learning and systems biology. In 2014, he joined the University of Maryland as Director of... read moreits Center for Bioinformatics and Computational Biology (CBCB). In 2018, he moved to the NCI where he founded and is Chief of its Cancer Data Science Lab/Branch (CDSL, https://ccr.cancer.gov/cancer-data-science-laboratory). His research is focused on developing new computational approaches for advancing precision oncology, leading to a few ongoing clinical trials. Eytan is a fellow of the International Society for Computational Biology (ISCB), a recipient of the NCI Director award for his work on precision oncology (2022), the DeLano award for computational biosciences for his work on synthetic lethality (2023) and the NIH director award for developing new computational paradigms for precision oncology (2024). He is a member of GSK Oncology scientific advisory board and a co-founder of a few precision medicine startup companies.